Media

Filter by Category

All Blog News Newsletters Podcasts Presentations Press Releases Publications Videos

Filter by Program

Filter by Publish Date

April 29, 2022

View Now | C-Path in Europe: Moving Global Regulatory Science Forward

In support of C-Path’s mission to catalyze innovation that accelerates the path to a healthier world, we’re excited

March 28, 2022

C-Path thanks and commends FDA for inviting public comments as part of the creation of a guidance document for Digital Health...

The Clinical Outcomes Assessment (COA), Critical Path for Parkinson’s Digital Drug Development (3DT) Initiative, and Type 1 Diab

C-Path in Europe works seamlessly with its U.S. counterpart to advance the development of novel regulatory-endorsed methodologies

March 21, 2022

March 21, 2022

C-Path’s Huntington’s Disease Regulatory Science Consortium (HD-RSC) has published a new paper on volumetric MRI-based biomark

March 18, 2022

Sensor data from digital health technologies (DHTs) used in clinical trials provides a valuable source of information...

March 18, 2022

Critical Path for Parkinson’s members, advisors and staff submitted six posters on behalf of CPP and CPP’s digital effort, Dig

March 11, 2022

The development of therapies to prevent or delay the onset of type 1 diabetes (T1D) remains challenging, and there is a lack of qu

The endeavor represents a major milestone for C-Path TUCSON, Ariz., March 10, 2022 — Critical Path Institute (C-Path) and